1. Home
  2. VCEL vs WD Comparison

VCEL vs WD Comparison

Compare VCEL & WD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

N/A

Current Price

$32.55

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo Walker & Dunlop Inc

WD

Walker & Dunlop Inc

N/A

Current Price

$46.96

Market Cap

2.1B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VCEL
WD
Founded
1989
1937
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.1B
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
VCEL
WD
Price
$32.55
$46.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$58.50
$78.33
AVG Volume (30 Days)
416.0K
410.4K
Earning Date
05-18-2026
05-29-2026
Dividend Yield
N/A
5.76%
EPS Growth
60.00
N/A
EPS
0.32
1.64
Revenue
$276,259,000.00
$1,234,306,000.00
Revenue This Year
$19.09
$20.09
Revenue Next Year
$17.96
$7.82
P/E Ratio
$102.78
$28.75
Revenue Growth
16.45
8.99
52 Week Low
$29.24
$42.12
52 Week High
$48.75
$90.00

Technical Indicators

Market Signals
Indicator
VCEL
WD
Relative Strength Index (RSI) 32.64 33.36
Support Level $31.34 $42.12
Resistance Level $38.48 $66.25
Average True Range (ATR) 1.37 3.22
MACD -0.39 -0.53
Stochastic Oscillator 3.03 24.92

Price Performance

Historical Comparison
VCEL
WD

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About WD Walker & Dunlop Inc

Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.

Share on Social Networks: